nitrocellulose membranes (R&D Systems)
R&D Systems is a verified supplier 
R&D Systems manufactures this product 
96
Structured Review
R&D Systems
nitrocellulose membranes
Nitrocellulose Membranes, supplied by R&D Systems, used in various techniques. Bioz Stars score: 96/100, based on 545 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/cytokine+antibody+array+membrane/Proteome+Profiler+Human+Cytokine+Array+Kit/pm41205495-59-32-35
Average 96 stars, based on 545 article reviews
Nitrocellulose Membranes, supplied by R&D Systems, used in various techniques. Bioz Stars score: 96/100, based on 545 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/cytokine+antibody+array+membrane/Proteome+Profiler+Human+Cytokine+Array+Kit/pm41205495-59-32-35
Average 96 stars, based on 545 article reviews
nitrocellulose membranes - by Bioz Stars,
2026-09
96/100 stars
Images
Related Articles
Ab Array:Article Title: Impact of Fetal Umbilical Cord Blood CD34+ Cells on Breast Cancer Cell Lines: A Mechanism of Fetal Microchimerism. Article Snippet: Introduction: Fetal microchimerism could be involved in the regulation of breast cancer oncogenesis.. CD34+ cells could be of a particular interest as up to 12% of the CD34+ population in maternal blood are of fetal origin.. The aim of this research was to analyze the impact of umbilical cord blood (UCB) CD34+ on MCF-7 and MDA-MB-231 breast cancer cell lines, in order to uncover novel biological mechanisms and suggest novel treatment options for breast cancer. Membrane:Article Title: Impact of Fetal Umbilical Cord Blood CD34+ Cells on Breast Cancer Cell Lines: A Mechanism of Fetal Microchimerism. Article Snippet: Introduction: Fetal microchimerism could be involved in the regulation of breast cancer oncogenesis.. CD34+ cells could be of a particular interest as up to 12% of the CD34+ population in maternal blood are of fetal origin.. The aim of this research was to analyze the impact of umbilical cord blood (UCB) CD34+ on MCF-7 and MDA-MB-231 breast cancer cell lines, in order to uncover novel biological mechanisms and suggest novel treatment options for breast cancer. |